Loading…
Selvas AI acquired a 31.69% stake in Mediana for 73.2 billion won ($56.7 million), becoming the largest shareholder. The deal includes a share transfer from Mediana's chairman and a capital increase, with Selvas Healthcare also participating.
“This agreement is based on the judgment that convergence with AI and SW technologies is essential for the core competitiveness of future medical devices.”koreabiomed.com
Summarized from public sources; check the original articles before acting on it.